Skandinaviska Enskilda Banken AB publ Boosts Position in Oscar Health, Inc. $OSCR

Skandinaviska Enskilda Banken AB publ grew its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 58.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 281,500 shares of the company’s stock after buying an additional 103,500 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Oscar Health were worth $6,040,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the company. Hsbc Holdings PLC grew its position in shares of Oscar Health by 2.7% during the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company’s stock worth $313,000 after buying an additional 632 shares in the last quarter. Wealthspire Advisors LLC grew its position in shares of Oscar Health by 6.7% during the 2nd quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company’s stock valued at $238,000 after acquiring an additional 700 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Oscar Health by 14.4% during the 2nd quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company’s stock worth $153,000 after purchasing an additional 900 shares during the last quarter. Focus Partners Wealth lifted its stake in Oscar Health by 1.8% in the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock worth $723,000 after purchasing an additional 949 shares in the last quarter. Finally, LRI Investments LLC boosted its stake in Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after buying an additional 975 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $17.92 on Monday. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.80. The business has a 50 day simple moving average of $18.16 and a 200-day simple moving average of $16.94. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $4.74 billion, a price-to-earnings ratio of -16.00 and a beta of 1.88.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. The company had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The firm’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same period last year, the business posted ($0.22) earnings per share. Oscar Health has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insider Activity

In other Oscar Health news, insider Mario Schlosser sold 286,182 shares of Oscar Health stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $15.27, for a total transaction of $4,369,999.14. Following the transaction, the insider owned 501,148 shares of the company’s stock, valued at $7,652,529.96. The trade was a 36.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 24.39% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on OSCR. Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $13.00 to $25.00 in a research report on Tuesday, November 25th. Barclays upped their price target on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research note on Monday, November 10th. Wall Street Zen upgraded shares of Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat.com, Oscar Health has an average rating of “Reduce” and a consensus price target of $14.86.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.